Industry
MYnd Analytics
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
3(60.0%)
Phase 4
1(20.0%)
Phase 2
1(20.0%)
5Total
N/A(3)
Phase 4(1)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT01794559Not ApplicableSuspended
Study to Evaluate the Safety and Efficacy of PEER Interactive Versus Treatment as Usual in Subjects With a Primary Diagnosis of Depression
Role: lead
NCT02988076Phase 2Suspended
Study to Evaluate the Safety and Efficacy of PEER Interactive to Inform Medication Prescription for Subjects With a Primary Diagnosis of Depression
Role: lead
NCT03625271Not ApplicableUnknown
The Canadian Armed Forces PEER Study
Role: lead
NCT03328052Phase 4Unknown
MYnd Analytics Directed Therapy in Depression
Role: collaborator
NCT00437827Not ApplicableCompleted
rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure
Role: lead
All 5 trials loaded